Post

Gay and bisexual men have higher risk of anxiety and depression

On 24 May, the 2024 Canadian Men’s Health Report was released; the national study surveyed 2,070 men over the age …

Oncolytics doses first subject in pancreatic cancer trial

Oncolytics Biotech has dosed the first patient with a combination therapy of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) for metastatic pancreatic …

Keymed reports positive data of CM313 in immune thrombocytopenia trial

Keymed Biosciences has reported positive safety and efficacy data of CM313 in adult patients with primary immune thrombocytopenia (ITP) as …

Microbot partners with Boston Hospital to trial Liberty surgical robot

US-based medical device company, Microbot Medical has announced that the Brigham and Women’s Hospital in Boston, Massachusetts will serve as …

Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial

Jazz Pharmaceuticals’ suvecaltamide has failed to meet primary or key secondary endpoints in a Phase IIb essential tremor (ET) trial. The …